back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
528,834 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-28,820
-131,000 vol $0.22 each |
719,000 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+34,500 vol $0.10 each |
367,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+10,000 vol $0.125 each |
397,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+20,000 vol $0.125 each |
387,834 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
850,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
||
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+150,000 vol $0.35 each |
600,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,500
+450,000 vol $0.35 each |
450,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+25,000 vol $0.35 each |
175,000 | |
| Filed 2018-04-17 Tx date 2018-04-11 |
$VANC
Vanc Pharmaceuticals Inc. |
Ratzlaff, Leanne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,250
+25,000 vol $0.21 each |
25,000 | |
| Filed 2018-04-17 Tx date 2018-04-11 |
$VANC
Vanc Pharmaceuticals Inc. |
Ratzlaff, Leanne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-04-17 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Holder: 1160305 B.C. Ltd. (Control or Direction)
|
Warrants
50 - Grant of options
|
$999,999
+3,030,303 vol $0.33 each |
3,030,303 | |
| Filed 2018-04-17 Tx date 2017-11-28 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Holder: 1160305 B.C. Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-27 Tx date 2018-03-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+200,000 vol $0.24 each |
200,000 | |
| Filed 2018-03-27 Tx date 2018-03-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-05 Tx date 2018-02-02 |
$VANC
Vanc Pharmaceuticals Inc. |
Shim, Dong Hyun
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-05 Tx date 2018-02-02 |
$VANC
Vanc Pharmaceuticals Inc. |
Shim, Dong Hyun
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+150,000 vol $0.35 each |
150,000 | |
| Filed 2018-01-23 Tx date 2017-08-15 |
$VANC
Vanc Pharmaceuticals Inc. |
Guorgui, Sherif Seif
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-23 Tx date 2017-09-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Guorgui, Sherif Seif
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
150,000 | |
| Filed 2018-01-23 Tx date 2017-12-08 |
$VANC
Vanc Pharmaceuticals Inc. |
Guorgui, Sherif Seif
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,000
+25,000 vol $0.28 each |
175,000 | |
| Filed 2017-11-28 Tx date 2017-11-28 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,666,667 | ||
| Filed 2017-11-28 Tx date 2017-11-28 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,666,667 | ||
| Filed 2017-08-04 Tx date 2017-08-03 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+166,667 vol $0.15 each |
333,334 | |
| Filed 2017-08-04 Tx date 2017-08-03 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333
+166,667 vol $0.20 each |
333,334 | |
| Filed 2017-07-24 Tx date 2017-07-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
150,000 | |
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+166,667 vol $0.15 each |
166,667 | |
| Filed 2017-06-28 Tx date 2016-01-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,999
+333,333 vol $0.15 each |
333,333 | |
| Filed 2017-06-28 Tx date 2016-01-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,666
+333,333 vol $0.20 each |
333,333 | |
| Filed 2017-06-28 Tx date 2015-06-05 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333
+166,667 vol $0.20 each |
166,667 | |
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-12 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-100,000 vol |
0 | |
| Filed 2017-02-01 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-70,000 vol |
300,000 | |
| Filed 2017-02-01 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-437,500 vol |
0 | |
| Filed 2017-02-01 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-50,000 vol |
0 | |
| Filed 2017-01-30 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+300,000 vol $0.22 each |
370,000 | |
| Filed 2017-01-06 Tx date 2016-12-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-25,000
-12,500 vol $2.00 each |
0 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-37,500 vol |
12,500 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-1,312,500 vol |
437,500 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-900,000 vol |
300,000 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-300,000 vol |
100,000 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-150,000 vol |
50,000 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
beukman, eugene
4 - Director of Issuer
Holder: Pender Street Corporate Consulting Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-18,750 vol |
6,250 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-210,000 vol |
70,000 |